Levetiracetam in Sodium Chloride NDC 0143-9283

NDC codes

FDA NDC Directory

Product NDC (as listed)0143-9283Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00143-9283Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0143-9283-10	00143928310	10 BAG in 1 BOX (0143-9283-10) / 100 mL in 1 BAG (0143-9283-01)Marketed from Feb 8, 2025

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levetiracetam in Sodium Chloride
Generic name (nonproprietary): levetiracetam in sodium chloride
Active ingredients: Levetiracetam — 15 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: Hikma Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211356
Marketing start: Feb 8, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 0143-9283_f3105bfa-50ba-4e2f-8eae-0313242d8dcfSPL ID f3105bfa-50ba-4e2f-8eae-0313242d8dcfSPL set ID c723fd27-214c-45f6-b170-a3b807ffab07RxCUI 1193358, 1193360, 1193362UNII 44YRR34555

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400143928310 followed by a unit qualifier and the quantity

Package 00143-9283-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 12, 2024.

Indications (excerpt from the label)

Levetiracetam in Sodium Chloride Injection is indicated for adjunct therapy in adults (≥16 years of age) with the following seizure types when oral administration is temporarily not feasible: Partial-onset seizures ( 1.1 ) Myoclonic seizures in patients with juvenile myoclonic epilepsy (1.2) Primary generalized tonic-clonic seizures ( 1.3 ) 1.1 Partial-Onset Seizures Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy. 1.2 Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy Levetiracetam in Sodium Chloride Injection is indicated as adjunctive therapy in the treatment of myoclonic seizures…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211356

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211356
Product	Strength	Form · route	Labeler	Product NDC
Levetiracetam in Sodium Chloride	Levetiracetam 5 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9281
Levetiracetam in Sodium Chloride	Levetiracetam 10 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9282